Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- A4337 CilostazolSummary: PDE3 inhibitor
- A4340 PimobendanTarget: Phosphodiesterases (PDEs)Summary: Selective PDE3 inhibitor.Ca2+ channel sensitizer
- A4343 DyphyllineSummary: Pan-PDE inhibitor
- A4346 AminophyllineTarget: Phosphodiesterases (PDEs)Summary: Pan-PDE inhibitor
- A4349 S- (+)-RolipramSummary: CAMP-specific PDE4 inhibitor
- A4352 Anagrelide HClSummary: Thrombocytopenic agent
- A3178 AN-2728Summary: PDE4 inhibitor,anti-inflammatory compound
- A3665 NortadalafilSummary: PDE5 inhibitor
- A3683 Olprinone HydrochlorideSummary: Phosphodiesterase 3 (PDE3) inhibitor, selective
- A3713 PF-04447943Summary: PDE9 inhibitor